Status:
UNKNOWN
Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty
Lead Sponsor:
Guangzhou First People's Hospital
Conditions:
Arthroplasty
Nerve Block
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG) block in hip arthroplasty as a post-operative pain management technique, study the analgesia, opioid-sparin...
Detailed Description
PENG Block group (PG) will receive 0.5%Ropivacaine in 20 ml of saline. Sham Block group (SG) will receive 20 ml of saline Patient will be sedated with IV midazolam before nerve block. After peripheral...
Eligibility Criteria
Inclusion
- Patients scheduled for hip arthroplasty
Exclusion
- allergy to local anesthetics
- infection at the injection site
- patients receiving opioids for chronic analgesic therapy
- other lower limb neuropathies
- inability to comprehend visual analog scale (VAS)
- preexist cognitive dysfunction
Key Trial Info
Start Date :
September 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2021
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04480320
Start Date
September 10 2020
End Date
March 31 2021
Last Update
September 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou First Municipal People's Hospital
Guangzhou, Guangdong, China, 510180